These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27478786)

  • 1. Formulation and Physicochemical Characterization of Lycopene-Loaded Solid Lipid Nanoparticles.
    Nazemiyeh E; Eskandani M; Sheikhloie H; Nazemiyeh H
    Adv Pharm Bull; 2016 Jun; 6(2):235-41. PubMed ID: 27478786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
    Das S; Ng WK; Kanaujia P; Kim S; Tan RB
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation, characterization, and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles.
    Eskandani M; Barar J; Dolatabadi JE; Hamishehkar H; Nazemiyeh H
    Pharm Biol; 2015; 53(10):1525-38. PubMed ID: 25853953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marrubiin-loaded solid lipid nanoparticles' impact on TNF-α treated umbilical vein endothelial cells: A study for cardioprotective effect.
    Nakhlband A; Eskandani M; Saeedi N; Ghafari S; Omidi Y; Barar J; Garjani A
    Colloids Surf B Biointerfaces; 2018 Apr; 164():299-307. PubMed ID: 29413609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, physicochemical characterization, and anti-proliferative properties of Lawsone-loaded solid lipid nanoparticles.
    Rasouliyan F; Eskandani M; Jaymand M; Akbari Nakhjavani S; Farahzadi R; Vandghanooni S; Eskandani M
    Chem Phys Lipids; 2021 Sep; 239():105123. PubMed ID: 34403685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
    Eskandani M; Nazemiyeh H
    Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
    Thirupathi G; Swetha E; Narendar D
    Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myristic Acid Solid Lipid Nanoparticles Enhance the Oral Bioavailability and Therapeutic Efficacy of Rifaximin against MRSA Pneumonia.
    Zhang Y; Zhang A; Chen D; Xie S
    Curr Drug Deliv; 2024 Aug; ():. PubMed ID: 39143871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.
    Rawat MK; Jain A; Mishra A; Muthu MS; Singh S
    Ther Deliv; 2010 Jul; 1(1):63-73. PubMed ID: 22816120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation.
    Zewail MB; F Asaad G; Swellam SM; Abd-Allah SM; K Hosny S; Sallah SK; E Eissa J; S Mohamed S; El-Dakroury WA
    Int J Pharm; 2022 Aug; 624():122006. PubMed ID: 35820515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K; Reddy H; Murthy RS
    AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles.
    Ezzati Nazhad Dolatabadi J; Hamishehkar H; Eskandani M; Valizadeh H
    Colloids Surf B Biointerfaces; 2014 May; 117():21-8. PubMed ID: 24607519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid nanoparticles coated with cross-linked polymeric double layer for oral delivery of curcumin.
    Wang T; Ma X; Lei Y; Luo Y
    Colloids Surf B Biointerfaces; 2016 Dec; 148():1-11. PubMed ID: 27588376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization, and in vivo study of rhein solid lipid nanoparticles for oral delivery.
    Feng H; Zhu Y; Fu Z; Li D
    Chem Biol Drug Des; 2017 Nov; 90(5):867-872. PubMed ID: 28432812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.